View in EDS

Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.

Saved in:
Bibliographic Details
Title: Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Authors: Moore, Kathleen N.1,2 (AUTHOR) Kathleen-Moore@ouhsc.edu, Birrer, Michael J.1,3 (AUTHOR), Marsters, Jim4 (AUTHOR), Wang, Yulei4 (AUTHOR), Choi, YounJeong4 (AUTHOR), Royer-Joo, Stephanie4 (AUTHOR), Lemahieu, Vanessa4 (AUTHOR), Armstrong, Katy4 (AUTHOR), Cordova, Julie4 (AUTHOR), Samineni, Divya4 (AUTHOR), Schuth, Eva4 (AUTHOR), Vaze, Anjali4 (AUTHOR), Maslyar, Daniel1,4 (AUTHOR), Humke, Eric W.1,4 (AUTHOR), Hamilton, Erika P.5 (AUTHOR), Liu, Joyce F.6 (AUTHOR)
Source: Gynecologic Oncology. Sep2020, Vol. 158 Issue 3, p631-639. 9p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 145530953
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Moore%2C+Kathleen+N%2E%22">Moore, Kathleen N.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> Kathleen-Moore@ouhsc.edu</i><br /><searchLink fieldCode="AR" term="%22Birrer%2C+Michael+J%2E%22">Birrer, Michael J.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Marsters%2C+Jim%22">Marsters, Jim</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Yulei%22">Wang, Yulei</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Choi%2C+YounJeong%22">Choi, YounJeong</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Royer-Joo%2C+Stephanie%22">Royer-Joo, Stephanie</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lemahieu%2C+Vanessa%22">Lemahieu, Vanessa</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Armstrong%2C+Katy%22">Armstrong, Katy</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cordova%2C+Julie%22">Cordova, Julie</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Samineni%2C+Divya%22">Samineni, Divya</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schuth%2C+Eva%22">Schuth, Eva</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vaze%2C+Anjali%22">Vaze, Anjali</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maslyar%2C+Daniel%22">Maslyar, Daniel</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Humke%2C+Eric+W%2E%22">Humke, Eric W.</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hamilton%2C+Erika+P%2E%22">Hamilton, Erika P.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Joyce+F%2E%22">Liu, Joyce F.</searchLink><relatesTo>6</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Gynecologic+Oncology%22">Gynecologic Oncology</searchLink>. Sep2020, Vol. 158 Issue 3, p631-639. 9p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=145530953
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ygyno.2020.05.039
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 631
    Titles:
      – TitleFull: Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Moore, Kathleen N.
      – PersonEntity:
          Name:
            NameFull: Birrer, Michael J.
      – PersonEntity:
          Name:
            NameFull: Marsters, Jim
      – PersonEntity:
          Name:
            NameFull: Wang, Yulei
      – PersonEntity:
          Name:
            NameFull: Choi, YounJeong
      – PersonEntity:
          Name:
            NameFull: Royer-Joo, Stephanie
      – PersonEntity:
          Name:
            NameFull: Lemahieu, Vanessa
      – PersonEntity:
          Name:
            NameFull: Armstrong, Katy
      – PersonEntity:
          Name:
            NameFull: Cordova, Julie
      – PersonEntity:
          Name:
            NameFull: Samineni, Divya
      – PersonEntity:
          Name:
            NameFull: Schuth, Eva
      – PersonEntity:
          Name:
            NameFull: Vaze, Anjali
      – PersonEntity:
          Name:
            NameFull: Maslyar, Daniel
      – PersonEntity:
          Name:
            NameFull: Humke, Eric W.
      – PersonEntity:
          Name:
            NameFull: Hamilton, Erika P.
      – PersonEntity:
          Name:
            NameFull: Liu, Joyce F.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 00908258
          Numbering:
            – Type: volume
              Value: 158
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Gynecologic Oncology
              Type: main
ResultId 1